Tekla Capital Management as of June 30, 2016
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 143 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences (GILD) | 8.8 | $214M | 2.6M | 83.42 | |
| Celgene Corporation | 5.8 | $141M | 1.4M | 98.63 | |
| Biogen Idec (BIIB) | 4.5 | $109M | 451k | 241.82 | |
| Allergan | 4.4 | $107M | 464k | 231.09 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.6 | $89M | 1.0M | 86.02 | |
| Alexion Pharmaceuticals | 3.2 | $80M | 682k | 116.76 | |
| Incyte Corporation (INCY) | 2.9 | $70M | 881k | 79.98 | |
| Medtronic (MDT) | 2.4 | $59M | 684k | 86.77 | |
| BioMarin Pharmaceutical (BMRN) | 2.3 | $55M | 712k | 77.80 | |
| Regeneron Pharmaceuticals (REGN) | 2.2 | $54M | 154k | 349.23 | |
| Pfizer (PFE) | 2.1 | $52M | 1.5M | 35.21 | |
| Illumina (ILMN) | 2.1 | $52M | 371k | 140.38 | |
| Amgen (AMGN) | 2.1 | $52M | 342k | 152.15 | |
| UnitedHealth (UNH) | 1.9 | $47M | 331k | 141.20 | |
| Merck & Co (MRK) | 1.9 | $46M | 798k | 57.61 | |
| Abbott Laboratories (ABT) | 1.7 | $42M | 1.1M | 39.31 | |
| Johnson & Johnson (JNJ) | 1.7 | $41M | 337k | 121.30 | |
| Neurocrine Biosciences (NBIX) | 1.6 | $40M | 877k | 45.45 | |
| Eli Lilly & Co. (LLY) | 1.6 | $40M | 503k | 78.75 | |
| Shire | 1.5 | $37M | 202k | 184.08 | |
| Mylan Nv | 1.5 | $36M | 827k | 43.24 | |
| Alkermes (ALKS) | 1.4 | $35M | 806k | 43.22 | |
| Teva Pharmaceutical Industries (TEVA) | 1.4 | $34M | 672k | 50.23 | |
| AmerisourceBergen (COR) | 1.4 | $33M | 418k | 79.32 | |
| Molina Healthcare (MOH) | 1.1 | $27M | 538k | 49.90 | |
| Hca Holdings (HCA) | 1.1 | $26M | 335k | 77.01 | |
| Medicines Company | 1.0 | $24M | 704k | 33.63 | |
| Humana (HUM) | 0.9 | $23M | 129k | 179.88 | |
| GlaxoSmithKline | 0.9 | $22M | 509k | 43.34 | |
| Agilent Technologies Inc C ommon (A) | 0.9 | $22M | 496k | 44.36 | |
| Jazz Pharmaceuticals (JAZZ) | 0.9 | $22M | 157k | 141.31 | |
| CVS Caremark Corporation (CVS) | 0.9 | $21M | 224k | 95.74 | |
| AstraZeneca (AZN) | 0.8 | $21M | 684k | 30.19 | |
| Medivation | 0.8 | $19M | 317k | 60.30 | |
| Universal Health Services (UHS) | 0.7 | $18M | 135k | 134.10 | |
| SPDR S&P Biotech (XBI) | 0.7 | $16M | 294k | 54.09 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.6 | $15M | 58k | 257.34 | |
| Corsicanto Ltd conv bnd | 0.6 | $15M | 15M | 1.02 | |
| Novartis (NVS) | 0.6 | $14M | 170k | 82.51 | |
| Medical Properties Trust (MPW) | 0.6 | $14M | 920k | 15.21 | |
| Omega Healthcare Investors (OHI) | 0.6 | $14M | 413k | 33.95 | |
| Senior Housing Properties Trust | 0.6 | $14M | 671k | 20.83 | |
| Mallinckrodt Pub | 0.6 | $14M | 224k | 60.78 | |
| Alnylam Pharmaceuticals (ALNY) | 0.6 | $14M | 244k | 55.49 | |
| Welltower Inc 6.50% pfd prepet | 0.6 | $14M | 200k | 67.80 | |
| Thermo Fisher Scientific (TMO) | 0.5 | $13M | 86k | 147.76 | |
| Sanofi-Aventis SA (SNY) | 0.5 | $13M | 305k | 41.85 | |
| St. Jude Medical | 0.5 | $12M | 159k | 78.00 | |
| IDEXX Laboratories (IDXX) | 0.5 | $12M | 132k | 92.86 | |
| Zimmer Holdings (ZBH) | 0.5 | $12M | 102k | 120.38 | |
| Ardelyx (ARDX) | 0.5 | $12M | 1.4M | 8.73 | |
| Horizon Pharma | 0.5 | $12M | 750k | 16.47 | |
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $12M | 364k | 32.46 | |
| Physicians Realty Trust | 0.5 | $11M | 531k | 21.01 | |
| Ventas (VTR) | 0.5 | $11M | 153k | 72.82 | |
| Exelixis (EXEL) | 0.5 | $11M | 1.4M | 7.81 | |
| Paratek Pharmaceuticals | 0.4 | $11M | 763k | 13.91 | |
| Natera (NTRA) | 0.4 | $11M | 882k | 12.07 | |
| Cepheid | 0.4 | $10M | 334k | 30.75 | |
| Wright Medical Group Nv | 0.4 | $9.9M | 572k | 17.37 | |
| United Therapeutics Corporation (UTHR) | 0.4 | $9.9M | 93k | 105.92 | |
| Sabra Health Care REIT (SBRA) | 0.4 | $9.4M | 456k | 20.63 | |
| Medicines Company | 0.4 | $9.4M | 280k | 33.63 | |
| Heron Therapeutics (HRTX) | 0.4 | $8.9M | 492k | 18.05 | |
| Cepheid conv | 0.4 | $8.7M | 10M | 0.87 | |
| Centene Corporation (CNC) | 0.3 | $8.6M | 120k | 71.37 | |
| Cellectis S A (CLLS) | 0.3 | $8.2M | 310k | 26.59 | |
| Galapagos Nv- (GLPG) | 0.3 | $8.2M | 148k | 55.47 | |
| Puma Biotechnology (PBYI) | 0.3 | $7.8M | 260k | 29.79 | |
| Cytomx Therapeutics (CTMX) | 0.3 | $7.7M | 756k | 10.21 | |
| Supernus Pharmaceuticals note 7.500 5/0 | 0.3 | $7.7M | 2.0M | 3.84 | |
| Cynapsus Therapeutics | 0.3 | $7.7M | 460k | 16.75 | |
| Intra Cellular Therapies (ITCI) | 0.3 | $7.3M | 188k | 38.82 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.3 | $7.4M | 13M | 0.57 | |
| Akorn | 0.3 | $7.0M | 245k | 28.49 | |
| Juno Therapeutics | 0.3 | $7.0M | 182k | 38.44 | |
| Endologix | 0.3 | $6.9M | 551k | 12.46 | |
| Flamel Technologies | 0.3 | $6.7M | 624k | 10.74 | |
| Bristol-myers Squibb | 0.3 | $6.4M | 87k | 73.55 | |
| Foamix Pharmaceuticals | 0.2 | $6.1M | 966k | 6.35 | |
| Pieris Pharmaceuticals (PIRS) | 0.2 | $6.2M | 3.8M | 1.61 | |
| Retrophin | 0.2 | $5.9M | 330k | 17.81 | |
| LTC Properties (LTC) | 0.2 | $5.5M | 106k | 51.73 | |
| Icon (ICLR) | 0.2 | $5.0M | 72k | 70.01 | |
| Dynavax Technologies (DVAX) | 0.2 | $5.0M | 345k | 14.58 | |
| Egalet Corporation note 5.50% 4/1/20 | 0.2 | $5.3M | 7.0M | 0.75 | |
| Tenet Healthcare Corporation (THC) | 0.2 | $4.5M | 165k | 27.64 | |
| Sagent Pharmaceuticals | 0.2 | $4.3M | 287k | 14.98 | |
| Ultragenyx Pharmaceutical (RARE) | 0.2 | $4.3M | 88k | 48.91 | |
| Endo International (ENDPQ) | 0.2 | $4.5M | 286k | 15.59 | |
| Sage Therapeutics (SAGE) | 0.2 | $4.4M | 147k | 30.13 | |
| Epizyme | 0.2 | $4.1M | 400k | 10.24 | |
| Pra Health Sciences | 0.2 | $4.3M | 102k | 41.76 | |
| Allergan Plc pfd conv ser a | 0.2 | $4.2M | 5.0k | 833.60 | |
| DepoMed | 0.2 | $3.9M | 200k | 19.62 | |
| Valeant Pharmaceuticals Int | 0.2 | $3.9M | 192k | 20.14 | |
| Accelr8 Technology | 0.2 | $3.8M | 265k | 14.39 | |
| Impax Laboratories | 0.1 | $3.6M | 124k | 28.82 | |
| Community Health Systems (CYH) | 0.1 | $3.7M | 305k | 12.05 | |
| Ariad Pharmaceuticals | 0.1 | $3.7M | 502k | 7.39 | |
| Nevro (NVRO) | 0.1 | $3.7M | 50k | 73.76 | |
| Perrigo Company (PRGO) | 0.1 | $3.4M | 37k | 90.67 | |
| Karyopharm Therapeutics (KPTI) | 0.1 | $3.4M | 500k | 6.71 | |
| Auris Med Hldg | 0.1 | $3.5M | 834k | 4.19 | |
| Beigene (BGNE) | 0.1 | $3.5M | 117k | 29.80 | |
| McKesson Corporation (MCK) | 0.1 | $2.8M | 15k | 186.67 | |
| Novavax | 0.1 | $2.6M | 358k | 7.27 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.1 | $2.8M | 166k | 16.67 | |
| Immunomedics Inc note 4.750% 2/1 | 0.1 | $2.7M | 4.0M | 0.68 | |
| Forward Pharma A/s | 0.1 | $2.5M | 137k | 18.17 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $2.4M | 297k | 8.15 | |
| Arca Biopharma | 0.1 | $2.4M | 811k | 2.90 | |
| Allscripts Healthcare Solutions (MDRX) | 0.1 | $2.2M | 174k | 12.70 | |
| Bluebird Bio (BLUE) | 0.1 | $2.1M | 49k | 43.29 | |
| Dbv Technologies S A (DBVT) | 0.1 | $2.1M | 66k | 32.62 | |
| Care Cap Properties | 0.1 | $2.2M | 84k | 26.21 | |
| Merus N V (MRUS) | 0.1 | $2.1M | 260k | 8.13 | |
| Alliqua | 0.1 | $1.8M | 1.7M | 1.12 | |
| Kite Pharma | 0.1 | $2.1M | 41k | 50.00 | |
| Global Blood Therapeutics In | 0.1 | $2.1M | 125k | 16.59 | |
| Intellia Therapeutics (NTLA) | 0.1 | $1.9M | 87k | 21.35 | |
| Halozyme Therapeutics (HALO) | 0.1 | $1.7M | 200k | 8.63 | |
| Momenta Pharmaceuticals | 0.1 | $1.7M | 154k | 10.80 | |
| Merrimack Pharmaceuticals In note 4.500% 7/1 | 0.1 | $1.6M | 1.5M | 1.11 | |
| Uniqure Nv (QURE) | 0.1 | $1.8M | 241k | 7.37 | |
| Flex Pharma | 0.1 | $1.7M | 162k | 10.21 | |
| Amicus Therapeutics (FOLD) | 0.1 | $1.4M | 258k | 5.46 | |
| Merrimack Pharmaceuticals In | 0.1 | $1.5M | 286k | 5.39 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.1 | $1.4M | 133k | 10.31 | |
| Chimerix (CMRX) | 0.1 | $1.2M | 309k | 3.93 | |
| Inotek Pharmaceuticals | 0.1 | $1.3M | 181k | 7.44 | |
| Esperion Therapeutics (ESPR) | 0.0 | $1.0M | 103k | 9.88 | |
| Revance Therapeutics (RVNC) | 0.0 | $1.0M | 75k | 13.60 | |
| GenMark Diagnostics | 0.0 | $812k | 93k | 8.70 | |
| Tetraphase Pharmaceuticals | 0.0 | $827k | 192k | 4.30 | |
| Affimed Therapeutics B V | 0.0 | $730k | 294k | 2.48 | |
| Bellicum Pharma | 0.0 | $778k | 60k | 12.97 | |
| Quorum Health | 0.0 | $815k | 76k | 10.71 | |
| Celldex Therapeutics | 0.0 | $465k | 106k | 4.39 | |
| Xencor (XNCR) | 0.0 | $380k | 20k | 19.00 | |
| Rmr Group Inc cl a (RMR) | 0.0 | $230k | 7.4k | 30.91 | |
| Abbvie (ABBV) | 0.0 | $10k | 156.00 | 64.10 | |
| Zafgen | 0.0 | $80k | 13k | 6.01 |
